Graph not available
Graph not available

Open Demat Account

50years
50 Years
of Trust & Legacy
₹0 AMC
for First Year
₹0 Brokerage
on Delivery, Intraday, Currency and NSE F&O
left-arrow
Fundamentals
Financials
Shareholding
Resistance/Support
Delivery and Volume
About
Management
News
Similar Stocks
right-arrow

Indraprastha Medical Corporation Ltd Performance

Today's Low
238.75
arrowIcon
Today's High
246.00
52 Wk Low
81.90
arrowIcon
52 Wk High
282.80


Open

246

Traded Value (Cr)

7.23 Cr

Prev. Close

246

VWAP

242.39

Volume

1,29,479

Face Value

10

Indraprastha Medical Corporation Ltd Financials

Indraprastha Medical Corporation Ltd Financials

Indraprastha Medical Corporation Ltd Shareholding Pattern

Held By Mar 2024 Dec 2023 Sep 2023 Jun 2023
Promoters 51.00 % 51.00 % 51.00 % 51.00 %
Retail 29.58 % 29.32 % 28.94 % 29.31 %
Others 18.34 % 18.73 % 19.26 % 19.31 %
FII 1.08 % 0.95 % 0.80 % 0.37 %
Mutual Funds 0.00 % 0.00 % 0.00 % 0.00 %

Promoters

51.00%

Retail

29.58%

Others

18.34%

FII

1.08%

Mutual Funds

0.00%

Promoters

51.00%

Retail

29.32%

Others

18.73%

FII

0.95%

Mutual Funds

0.00%

Promoters

51.00%

Retail

28.94%

Others

19.26%

FII

0.80%

Mutual Funds

0.00%

Promoters

51.00%

Retail

29.31%

Others

19.31%

FII

0.37%

Mutual Funds

0.00%

Resistance and Support

₹243.73

PIVOT

resistance-arrow
Resistance
First Resistance₹252.467
Second Resistance₹264.733
Third Resistance₹273.467
support-arrow
Support
First Resistance₹231.467
Second Resistance₹222.733
Third Resistance₹210.467
RSI56.092
MACD15.728
ADX52.278
CCI-27.304

Delivery and Volume

PeriodDelivery Volume Traded Volume Delivery Volume %
Day129,47968,12152.61
Week245,926156,41660.10
1 Month590,373362,86364.13
6 Months449,249275,51261.33

About Indraprastha Medical Corporation Ltd

Indraprastha Medical Corporation was incorporated as Public Company on 16th March, 1988. The main business of the company is to enhance the quality of life of patients by providing comprehensive, high-quality hospital services on a cost-effective basis. The company came out with the public issue of 2,29,18,300 equity shares of Rs 10 each for cash at par aggregating Rs 22,91,83,000. IMCL is setting up a multi-disciplinary super speciality teritary care referral hospital at New Delhi. The hospital was originally planned to be located within the Indira Gandhi indoor stadium complex, Mahatma Gandhi Marg, New Delhi. In 1998-99, stroke unit to cater for strokes (Brain attack) with 4 beds has been established and a new OT complex consisting of 6 operation theatres has been commissioned. It has even set up a body mind medicine department based on ancient Eastern philosophy. During 1999-2000, the company signed a MOU with the Governments of Tanzania and Mauritius to treat patients from these countries sponsored by their Governments. It also has tie-ups with private air transport companies to transfer critical cases. A Puva UV therapy unit, for treatment of complex skin conditions, has been added in the dertamology department. The hospital has also installed an automated system in the microbiology unit for rapid cultures. A satellite clinic of the hospital, providing out door consultations and diagnostic facilities, was opened in Feb.'2001, in Delhi. This clinic also functions as a referral and sample collection centre for laboratory investigation. A high energy linear accelerator was installed with multileaf collimeter enabling selective radiation to the affected part sparing normal tissue. A four digit telephone number '1066' was introduced by the Hospital for Emergency Medical Services and this is the first of its kind in the country. Three more super specialites namely Joint replacement,Spinal disorders and vascular surgeries have been started in the Hospital. The HIS is nearing completion and will be fully operational in the fag end of this financial year. During October 2001 the Hospital opened the Satellite Clinic at Golf Link,New Delhi. The new 57-bed Apollo Hospital in Noida offering secondary and tertiary services became operational in 2006. A specialized Clinic for Chest Pain under the banner Apollo Chest Pain Centre (ACPC)' was launched in three locations, Bansal Hospital in Friends Colony, Sehgal Nursing Home in Paschim Vihar and the Apollo Clinic in Vasant Kunj, New Delhi. During 2009-10, Indraprastha Apollo Hospitals introduced Endoscopic Ultra Sonology (EUS), a major advancement in diagnosing and treating gastrointestinal and pancreato-biliary diseases. The Multi Organ Transplant unit of the Hospital performed 268 organ transplants in the financial year 2009-10 (117 liver and 151 kidney transplants). Significant renovation and upgradation work was completed during the year, which should add to patient comfort and help achieve more operational efficiencies. Among others, a new orthopaedics operation theatre, a 5-bed ICU for critical cardiac care patients, a 12 bed Multi Organ Transplant Unit for Renal Transplant patients, a Mezzanine in the atrium for ICU patient attendants and international patient lounge were commissioned. 58 patient rooms and 3 OPDs were also renovated. A new Endoscopic Ultrasound Unit was commissioned in 2010-11. A Bone Marrow Transplant Unit, one of the highest end of medical services, was also created in the Hospital for intensive treatment and management of certain cancers like leukemia, lymphomas and also some non-cancerous diseases like thalessaemia. A multi organ transplant unit was added to the increasing organ transplant demands. Renovated four OPD wings and day care facility. An OP pharmacy, OPD billing counter, Insurance TPA help desk and ICU patient lobby have been setup for the comfort and ease of patients. The expansion project undertaken by the Hospital was completed in 2011. In addition, a Cosmetic Centre was set up to provide aesthetic medicine on an out-patient basis. Out of the additional beds, 50 beds were commissioned. As part of the ongoing upgradation and renovation programme, a number of departments and units such as Gynecology & Pediatric OPD, Sample collection; Chemotherapeutics Admixture Room; Telemedicine Room; Fetal Medicine; Nucleic Acid Testing (NAT) Laboratory and Staff Cafeteria were refurbished to increase patient comfort and enhance operational efficiency. In order to meet the pressing demand of Dialysis and increased number of renal transplants, seven additional beds were commissioned in the Dialysis unit taking the capacity to 28. A new Out Patient Wing (OPD 2C) - with 14 Consultation rooms was commissioned in place of 28 general ward beds, to accommodate the new Consultants. The Expansion Project undertaken by the main Hospital to add 127 additional Beds comprising of 74 single rooms, 33 general ward beds and 20 ICU beds, was completed. With the completion of the expansion project, the total bed strength of the Hospital has increased to 710 beds in 2012-13. The Apollo Institute of Robotic Surgery was launched in June, 2012 and has been performing a good number of robotic surgeries with the Da-Vinci Robotic Surgical System. The Hospital commissioned the Cosmetic Clinic in 2012. In 2013-14, the Apollo Obesity and Metabolic Surgery (Bariatric surgery) Centre was commissioned. The Apollo Institute of Robotic Surgery, which was instituted last year, performed 173 surgeries during the year. The Renal Transplant services were commenced in September, 2013 and resulting to this, a total of 18 transplants were conducted in the Noida hospital during the year. The Pain Clinic was started in January 2014 offering integrated and comprehensive Pain Management for all kinds of pain. Given the rising burden of Non-Communicable Diseases and Diabetes, the Sugar Clinic was also started to help patients in better management of Diabetes and prevention of associated complications. The hospital also expanded its Emergency department with 10 additional beds being added along with a complete renovation. The total strength of the unit stands at 20 beds. Also, the Urology, Nephrology and Dermatology OP areas underwent renovation. A large number of equipments were replaced or upgraded in various specialities including Oncology, Fetal Medicine, Cosmetics, Cardiology and Microbiology along with OT and other equipment at the main hospital and in Noida. Project Priceless, an Apollo wide initiative supported by inputs from Bain & Company, to improve overall patient experience and improve patient and physician advocacy for the Hospital, commenced in June, 2014. Plastic and Cosmetic Surgery: New Anti-aging procedures have been introduced such as Mid-face volumization; Skin lifting and tightening 'Ulthera procedure' for face, upper neck, lower neck and arms; and Cool Sculpting for non-invasive localized fat reduction for body contouring. In addition, a multitude of new investigation services have been started including Chromosomal Genetic Study, Contrast Enhanced Ultrasonography, etc. Various new Diagnostic or Surgical processes have also been added in different specialties such as Clot Evacuation in Urology, Tracheal or Bronchial Stent placement in Respiratory medicine, FET PET MRI for better imaging of brain tumours, Molecular Imaging, Nuclear Medicine, etc. The Central Asia e-Network link was launched on 12th July 2015. The event featured a tele-consultation for a cardiac patient between doctors in Osh city in Southern Kyrgyzstan, in Bishkek and with Apollo Hospital and AIIMS. The Hospital completed a successful cadaver split liver transplant wherein both the parts of the liver were given to two adult recipients. This was the first split liver transplant in two adults reported in the city and the second in India. Indraprastha Apollo Hospitals started providing Geriatric Services starting December 2016. New technique of Molecular Micro Film Array (Biofire) for rapid detection of micro-organisms in cases of meningitis/ encephalitis, sepsis, respiratory infections and gastroenteritis were introduced in Molecular Microbiology. In 2018-19, the Hospital commissioned a new state-of-the-art Chemotherapy Unit with 30 beds. During 2021-22, the Bone Marrow Transplant (BMT) project Unit, created a dedicated wing for BMT unit with 8 single rooms, 3 general ward beds and 1 procedure room, which was commissioned in August 2021. Bronchoscopy and PFT lab were cohorted in one area to make it man-power optimal. A 25-bedded Dialysis Unit was created in the Lower Basement of the hospital to create a better patient experience. Orthopaedic operating theatre was moved from Ground Floor to the first floor so that all theatres are cohorted in one area. The Radiology Unit was renovated to improve patient experience.

Managing Director

P Shivakumar

Founded

1988

NSE Symbol

INDRAMEDCO

Indraprastha Medical Corporation Ltd Management

NameDesignation
Jasmine ShahChairman & Non Executive Dir.
Prathap C ReddyVice Chairman & Non executive
Suneeta ReddyNon Executive Director
Sangita ReddyNon Executive Director
Vineeta RaiNon Executive Director
S RegunathanIndependent Non Exe. Director
Satnam AroraIndependent Non Exe. Director
Deepak VaidyaIndependent Non Exe. Director
Arun RaiIndependent Non Exe. Director
Vinayak ChatterjeeIndependent Non Exe. Director
MADHUMITA GANGULIIndependent Non Exe. Director
Menaka GurusswamyIndependent Non Exe. Director
Salil SinghalIndependent Non Exe. Director
Vikram BhatNon Executive Director
Mahesh VermaNon Executive Director
P ShivakumarExecutive Director & MD
Tejpreet S ChopraIndependent Director

Indraprastha Medical Corporation Ltd News

Indraprastha Medical Corporation to hold board meeting
On 17 May 2024
Indraprastha Medical Corporation receives affirmation in credit ratings
From ICRA
Indraprastha Medical Corporation schedules board meeting
On 7 March 2024
Indraprastha Medical Corporation standalone net profit rises 40.86% in the December 2023 quarter
Sales rise 10.66% to Rs 306.46 crore
Indraprastha Medical Corporation to conduct board meeting
On 6 February 2024
Indraprastha Medical Corporation announces cessation of director cum chairman
Indraprastha Medical Corporation standalone net profit rises 30.72% in the September 2023 quarter
Sales rise 11.47% to Rs 317.00 crore
Indraprastha Medical Corporation to conduct board meeting
On 3 November 2023
Indraprastha Medical Corporation to hold AGM
On 21 September 2023
Indraprastha Medical Corporation standalone net profit rises 50.39% in the June 2023 quarter
Sales rise 16.40% to Rs 306.51 crore

Similar Stocks

CompanyMarket CapMarket PriceP/E Ratio
APOLLOHOSP₹ 83,487 Cr
₹ 5,806.40
(-0.69 %)
83.62
MAXHEALTH₹ 77,378 Cr
₹ 796.15
(-0.99 %)
135.24
MEDANTA₹ 37,529 Cr
₹ 1,397.70
(-1.21 %)
107.24
FORTIS₹ 34,131 Cr
₹ 452.10
(-2.30 %)
447.18
NH₹ 25,393 Cr
₹ 1,242.60
(-2.25 %)
70.87

Indraprastha Medical Corporation Ltd FAQ

By opening a demat account and having your KYC papers confirmed online, you may simply purchase Indraprastha Medical Corporation Ltd shares in BlinkX

The share price of any stock is volatile and changes during the day due to a variety of variables. Indraprastha Medical Corporation Ltd's share price is ₹240.55 as of May 9, 2024

The 52-week high/low price of a Indraprastha Medical Corporation Ltd stock is the highest and lowest price at which it has traded over that period (about one year) and is used as a technical indicator. Indraprastha Medical Corporation Ltd's 52-week high and low as of May 9, 2024 are ₹246 and ₹238.75 respectively.

As of the Mar 2024 quarter, the promoter shareholding in Indraprastha Medical Corporation Ltd stands at 51.00%. During the same period, Institutional Investors have shown a slight increase in their holdings, rising from 0.95% to 1.08%.